Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer

Overview of attention for article published in Pathology, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 1,804)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 11 news outlets
twitter: 2 X users

patent: 1 patent

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 11 news stories from 11 outlets.

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

WGN9, 13 Jul 2023

Lab service utilizes Envision Science's proprietary biomarkers and technology with a goal of improving diagnosis and grading of…

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

FOX31 Denver KDVR-TV, 13 Jul 2023

Please enter a search term. Please enter a search term. News provided by Jul 13, 2023, 8:45 AM ET Lab service utilizes Envision…

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

Morning Star, 13 Jul 2023

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading PR Newswire SECAUCUS, N.J.

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

Ticker Tech, 13 Jul 2023

Lab service utilizes Envision Science's proprietary biomarkers and technology with a goal of improving diagnosis and grading of…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 7 additional news stories.